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Excess of Twins among Affected Sibling Pairs with Autism: Implications for
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It is widely accepted that genes play a role in the etiology of autism. Evidence for this derives, in part, from twin
data. However, despite converging evidence from gene-mapping studies, aspects of the genetic contribution remain
obscure. In a sample of families selected because each had exactly two affected sibs, we observed a remarkably
high proportion of affected twin pairs, both MZ and DZ. Of 166 affected sib pairs, 30 (12 MZ, 17 DZ, and 1
of unknown zygosity) were twin pairs. Deviation from expected values was statistically significant ( for56P ! 10
all twins); in a similarly ascertained sample of individuals with type I diabetes, there was no deviation from expected
values. We demonstrate that to ascribe the excess of twins with autism solely to ascertainment bias would require
very large ascertainment factors; for example, affected twin pairs would need to be, on average, ∼10 times more
likely to be ascertained than affected nontwin sib pairs (or 7 times more likely if “stoppage” plays a role). Either
risk factors (related to twinning or to fetal development) or other factors (genetic or nongenetic) in the parents
may contribute to autism.
Introduction
It is widely accepted that autism [MIM 209850] is ex-
tensively influenced by genetic factors (Smalley et al. 1988;
Bailey et al. 1995). However, despite converging evidence
from gene-mapping studies (e.g., International Molecul-
ar Genetic Study of Autism Consortium 1998, 2001; Ash-
ley-Koch et al. 1999; Barrett et al. 1999; Philippe et al.
1999; Risch et al. 1999; Auranen et al. 2000; Buxbaum
et al. 2001), it remains unclear what other factors may
play a role in the risk for autism. In particular, there is
controversy over whether perinatal factors play a role in
the etiology of autism—and, if so, whether that role is
causal or ancillary (Steffenburg et al. 1989; Bailey et al.
1995; Trottier et al. 1999). Yet another possibility is that
factors in the mother—such as autoimmunity (Comi et
al. 1999) or bleeding during pregnancy (Torrey et al.
1975)—may affect the development and/or perinatal en-
vironment of the fetus; however, such factors have re-
ceived less attention.
In an extensive data-collection initiative, the Autism
Genetic Resource Exchange (AGRE) of the Cure Autism
Now (CAN) Foundation is collecting genotype and clin-
ical data on a large cohort of families ascertained through
at least two siblings with autism or autism-related con-
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ditions (e.g., pervasive developmental delay [PDD] or As-
perger syndrome) (Geschwind et al. 2001). These data
are being collected under the supervision of the Human
Biological Data Interchange (HBDI). During evaluation
of these pedigrees, we noticed a striking and dramatic
excess of twin pairs in the data set, compared with the
highest population frequencies that reasonably could be
expected: among affected sib pairs (ASPs), we observed
a 4–5-fold increase for DZ twins and much more than
a 10-fold increase for MZ twins. These increases were
statistically significant.
This observation, if confirmed, would indicate that
simply being a twin represents a risk factor for autism.
This risk may originate in the environmental conditions
in the womb, including competition for nutrients, ob-
stetric complications, or factors in the mother that pre-
dispose to autism—whether these factors are intrauterine,
perinatal, immune-related, or inherited factors related to
pregnancy, or even in vitro fertilization (IVF), although
IVF is associated with an increase only in DZ, not MZ
multiple births.
In this article, we describe the striking increase in twin
pairs among the ASPs in the study.We demonstrate that,
if this increase is due to sampling issues rather than to
biological factors, then the required ascertainment-bias
factor must be very high.
Data
For genetic studies, the AGRE and the HBDI recruit
families with at least two affected relatives—most of
whom are affected sibs—with autism and/or either PDD
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Table 1
Distribution of ASPs
GROUP
NO. IN DIAGNOSTIC CATEGORYa
Narrow Broad Total
Singletons 82 (47,32,3) 54 (28,21,5) 136 (75,53,8)
DZ twin 8 (6,2,0) 4 (2,2,0) 12 (8,4,0)
MZ twin 15 (14,—,1) 2 (1,—,1) 17 (15,—,2)
UZ twins 1 (1,0,0) 0 (0,0,0) 1 (1,0,0)
Total 106 (68,34,4) 60 (31,23,6) 166 (99,57,10)
a Numbers in parentheses indicate breakdown into male-male,
mixed sex (if applicable), and female-female, respectively. UZ p un-
known zygosity.
or Asperger syndrome. Families are recruited both via
mailings requesting participation, sent to members of
CAN, and via presentations given at meetings of autism
support groups and the Autism Society of America. No
families are recruited through physicians. Families with
MZ twins are not particularly sought, since one of the
purposes of the AGRE is to collect families for linkage
studies, and MZ twins add no information for linkage.
After families have been identified, trained investi-
gators go to the family’s home and administer the Au-
tism Diagnostic Interview (Le Couteur et al. 1989). Af-
fected offspring are coded as having autism, PDD, or
Asperger syndrome. Most of the twins have undergone
genotyping, and their zygosity, originally reported by
parents, has been confirmed in all cases but one.
Although families with more than two affected off-
spring or with two or more other affected relatives are
included in the AGRE study, we limited the current anal-
ysis to families having exactly two affected offspring (i.e.,
having no affected trios, etc.), to simplify the calculations
and the handling of ascertainment. Also, we also did not
include families with “mixed twin pairs”—that is, fam-
ilies with one affected twin, one unaffected cotwin, and
a nontwin affected sib.
We divided the ASPs into two diagnostic categories:
“narrow” (i.e., both affected sibs have autism) and
“broad” (i.e., one or both of the affected members have
either PDD or Asperger syndrome). Table 1 shows the
observed distribution of ASPs, by diagnosis, by twin
status, and by sex distribution. Finally, we also exam-
ined data on similarly ascertained families from the
HBDI study of type 1 diabetes, or insulin-dependent
diabetes mellitus (IDDM), for comparison with the data
on autism.
Statistical Analysis
Across populations, published twinning rates (per birth)
vary widely for DZ twins but are fairly consistent for
MZ twins. We used values from Thompson et al. (1991),
who report, for European populations, rates of 1/125,
for DZ twins, and 1/260, for MZ twins, because these
values are at the high end of the ranges cited by Vogel
and Motulsky (1979). Expected twinning rates per sib
pair are approximately double the per-birth rates. (If rbirth
is the twinning rate per birth, and rpair is the rate per sib
pair, then , since rbirth isr p 2r /(1 r ) ≈ 2rpair birth birth birth
small.) Thus, the expected proportions of sib pairs who
are twin pairs are .016 (2/125) for DZ twins, .008 (2/
260) for MZ twins, and .024 for all twins.
We performed the statistical analyses on the narrow
and the total (i.e., narrow  broad) diagnostic groups.
The observed twinning rates in our sample showed sub-
stantial and statistically significant deviations from pop-
ulation rates (table 2).
Could these results be explained by preferential as-
certainment of twin ASPs over nontwin ASPs? To ex-
amine this question, we define the “ascertainment fac-
tor,” A, as the ratio of the probability that a twin ASP
will be ascertained versus the probability that a nontwin
ASP will be ascertained (see table 2). To explain our
observations, A would have to equal, for example, 11.9
for all twins (narrow diagnosis). This means that these
twin pairs would have to be 11.9 times more likely to
be ascertained than nontwin ASPs, in order to match
the excess of twins that we observed. Moreover, the
lower 95% confidence limit (95%CL) on that A is 7.2;
that is, 7.2 is the lowest possible value of the ascer-
tainment factor that could render our observations “not
significant” at the .05 significance level (two sided). The
results for MZ twins (narrow diagnosis) are even more
striking: A would have to be 122, with a lower limit of
almost 12.
For comparison, we also examined proportions of
twin pairs among ASPs in HBDI’s study of IDDM that
have been collected during the past ∼20 years, in a man-
ner similar to that used for the collection of data on
autism. Using the same criterion as was used for the
families with autism—that is, exactly two affected off-
spring—we identified 649 ASPs, 15 (13 MZ, 1 DZ, and
1 of unknown zygosity) of whomwere twins. Compared
to population rates, these observations represent a sta-
tistically significant deficit ( ) for DZ twins andP ! .001
a statistically significant excess ( ) for MZ twins;P ! .01
but for all twins there is no significant difference.
Discussion
We have documented a striking increase in the propor-
tion of twins among ASPs with autism, an excess not
observed in a similarly ascertained population of ASPs
with IDDM. We have also quantified the magnitude of
ascertainment bias that would be required to explain
this increase, if the increase is due to sampling issues,
without a biological basis. For example, twin ASPs over-
all would have to be ∼9–12 times more likely to be
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Table 2
Deviations, from Population Rates, of Observed Proportions of Twins—and Values of A That Are Needed to Explain
Observations
TWIN
GROUP
Population
Rate
NARROW DIAGNOSIS
NARROW  BROAD
DIAGNOSES
Rate Observed Pa
Ab
(Lower 95%CL) Rate Observed Pa
Ab
(Lower 95%CL)
DZ .016 .075 (8/106) !.001 5.9 (2.5) .072 (12/166) !.00005 5.4 (2.7)
MZ .008 .142 (15/106) !.000001 22.4 (11.8) .102 (17/166) !.000001 15.2 (8.7)
Allc .024 .226 (24/106) !.000001 11.9 (7.2) .181 (30/166) !.000001 9.0 (5.8)
a Two-sided, exact binomial calculations.
b , where r denotes rate of twin pairs (of specified type) among sib pairs and s denotesAp (r /s )/(r /s )observed observed population population
rate of nontwin pairs among sib pairs.
c Includes UZ twins, in addition to MZ and DZ twins.
ascertained than nontwin ASPs (or somewhat less if
“stoppage” plays a role; see below).
Furthermore, we did not include in the calculations
(a) two sibships, each with a twin ASP plus an affected
nontwin; (b) six “mixed twin pairs”; (c) three sets of
triplets, each with two affected members; and (d) one
set of quadruplets, all affected. The existence of these
sib groups, together with the twin data, suggest that
multiple birth is an important risk factor for autism.
Several questions concerning our findings arise: What
conditions must prevail if our findings are to be ex-
plained solely by ascertainment bias? How appropriate
a comparison sample is provided by the IDDM twin
data? What implications do our findings have for un-
derstanding the etiology of autism?
Ascertainment Bias
If ascertainment does explain the excess of twins in
this data set, how could such an ascertainment difference
arise? We consider several possibilities:
1. Parents of twins with autism may be much more
likely to volunteer for a genetic research study than are
parents of two nontwin children with autism. This ex-
planation might hold if (a) the burden of having two
children whose autism emerges simultaneously is much
greater than the burden of having two children whose
autism emerges 1 year apart and (b) the probability
of parents’ volunteering to participate in a genetic study
is proportional to this burden. These two factors may
hold but would have to be demonstrated.
2. Parents could be more likely to perceive autism as
being genetic when twins are affected than when non-
twin siblings are affected—and that this perception pre-
disposes them to participate in a genetic study.
3. MZ twins may have been turned away by other
genetic studies and therefore may participate dispro-
portionately in the AGRE study. Many genetic studies
of autism currently concentrate on linkage analyses, to
which MZ twin pairs contribute no information. The
AGRE, in contrast, collects twin data and also identifies
families for genetic linkage studies, although (as men-
tioned above) it does not preferentially collect twins.
Thus, conceivably, if MZ twins’ parents who want to
contribute to research have been turned away by other
studies, such twins may emerge in increased proportions
in the AGRE data set; however, this would not explain
the dramatic increase of DZ twins in the AGRE data
set, since DZ twins are just as acceptable for linkage
studies as are nontwin sib pairs.
4. The ascertainment differences may be the result of
“stoppage” (Jones and Szatmari 1988; Slager et al.
2001). In the extreme situation of “complete” stoppage,
in which parents always stop having children after the
birth of their first affected child, the only families to
have an ASP would be those with an affected twin pair
(or affected triplets, etc.) Although that is clearly not the
case in our data set, since it does not contain many
nontwin ASPs, stoppage still is a reasonable factor to
consider. The phenomenon of stoppage may be viewed
as a particular form of ascertainment bias, since, if stop-
page holds, some proportion, d, families who “would
have had” a second affected child fail to do so because
they have stopped having children after the first affected
child. Other calculations that we have done on the com-
plete data set (authors’ unpublished data) indicate that
the stoppage parameter, d, may be as high as 30%. In-
corporating d into our calculations would attenuate the
magnitude of the ascertainment factor A by a factor
, or ≈.7. Thus, for all twins, A would become 8.31 d
and 6.3, for the “narrow” and “total” diagnostic
groups, respectively, with lower 95%CLs of 5.0 and 4.1,
respectively. These reduced A values are still quite high.
Another factor arguing for twinness as a risk factor
for autism was the presence of a surprisingly large num-
ber (6/172) of families in which discordant twins were
present but in which a third, nontwin child had autism
and/or PDD. We did not include these in our calcula-
tions, because of assumptions that we would have had
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to make about the ascertainment mechanism. Nonethe-
less, these families provide additional evidence that being
a twin may be a risk factor for autism and/or PDD.
Data on Twins with IDDM
Another issue is whether the data on twins with IDDM
provide an appropriate comparison with data on twins
with autism. The families with IDDMwere recruited via
a mechanism similar to that used to recruit the families
with autism and, basically, via the same organization. It
is true that autism represents a much greater burden for
parents than does IDDM. However, the issue is not
whether twin ASPs with autism are more likely to be
ascertained than are twin ASPs with IDDM but whether
the increase in ascertainment of twin ASPs with autism
over nontwin ASPs with autism is greater than the in-
crease in ascertainment of twin ASPs with IDDM over
nontwin ASPs with IDDM. This could be the case, but
we know of no evidence for it.
The twinning rates among the ASPs with IDDM pre-
sented a less clearcut picture than did those among the
ASPs with autism. Compared with what would be ex-
pected on the basis of population rates, the rate for DZ
twins was lower but the rate for MZ twins was higher.
Moreover, the overall twinning rate among the ASPs
with IDDM was exactly as expected. Had the ASPs with
IDDM shown the same rate of twinning as did the ASPs
with autism, we would have expected to observe either
117 or 147 twin pairs overall (depending on whether
we used, respectively, the “narrow” or “total” rates in
table 2), among the 649 ASPs with IDDM—instead of
the 15 that we did observe. One might expect that the
number of twins in the IDDM data set would be greater
than what would be predicted on the basis of the pop-
ulation figures, if presence of a disease were a factor
affecting participation in the study. The fact that we did
not observe the same kind of excess of twinning in an-
other sample of ASPs with a serious disease, who were
ascertained via a mechanism similar to that used for the
sample with autism, provides some evidence, although
it is not conclusive, against ascertainment bias alone as
the explanation for the excess of twinning in the autism
data set.
Implications for Etiology of Autism
The observation of such a notable excess of multiple
births suggests several hypotheses. First, MZ twins are
more overrepresented than are DZ twins, thus supporting
the hypothesis that genetic factors do play a role in the
development of autism. However, if being a twin is an
important risk factor for autism and/or PDD, then one
must ask whether the difference in the MZ:DZ ratio in
autism is due to differences in the twinning processes for
MZ twins versus DZ twins or to the intrauterine envi-
ronment. For example, DZ twins develop from different
ova, whereas MZ twins develop from the same ovum.
Being monochorionic or monoamniotic may play a role
in the competition for intrauterine resources, since mon-
ochorionic twins may exhibit significantly more perinatal
mortality (Chitrit et al. 1999) and/or morbidity (Min-
akami et al. 1999) than do dichorionic twins. Also, since
MZ twins result from a splitting of a single ovum, the
reduction in the mass of the ovum may play a role. If, as
our study suggests, being a twin is a risk factor for autism,
then estimates, in the literature, of the genetic contribution
to autism that are derived from the MZ:DZ ratio may
be biased upward.
Second, if the magnitude of the MZ:DZ ratio is in
fact due to genetic factors, then the observation of
higher-than-expected proportions of twins, both MZ
and DZ, suggests that those genetic factors may be re-
lated to genes in the parents rather than to genes in the
offspring. In that case, linkage studies would need to
focus on parents of children with autism and/or PDD
and on the parents’ sibs. In such a case, the multiplex
families favored for linkage studies should consist of
adult siblings with affected offspring, rather than the
affected offspring themselves. Genetic effects may in-
volve the intrauterine environment, in which case either
the mother of the offspring with autism and/or PDD
would be the “affected” member or some unknown in-
teraction between the expression of paternal genes in the
offspring and the mother’s genetic complement could be
a factor (e.g., as in Rh incompatibility).
Third, there is undoubtedly heterogeneity within the
diagnosis of autism and/or PDD. The observation of
excess twins among offspring with autism may indicate
that the etiology in a notable proportion of offspring
with autism is related to intrauterine or perinatal factors.
On the other hand, the proportion of children with au-
tism for whom the putative maternal or perinatal effects
are primary may still be small, if those factors merely
modify direct genetic effects. In either case, it becomes
essential to attempt to differentiate between perinatally
related etiologies and genetically related etiologies.
Finally, if the phenomenon described here is real, then
why has no one else reported an excess of twins among
families with autism? The only studies related to this
question have been twin studies (i.e., studies whose en-
tire sample consisted of twin pairs). The investigators
compared the size of the total sample to the total “ex-
pected” number of affected twin pairs in the population
of the appropriate country. However, this approach
seems susceptible to error, since investigators may not
have ascertained all the affected twin pairs in that coun-
try. One of these studies (Gillberg and Steffenburg 1990)
reported a slight but nonsignificant excess of affected
twin pairs over what would be expected, and the other
did not (Bailey et al. 1995). To our knowledge, no one
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else has examined the number of twin pairs among a
sample of ASPs. Studies such as those by Philippe et al.
(1999) and Risch et al. (1999) do not record whether
their ASP samples included twin pairs—and, if so, how
many (although Risch et al. mention two twin ASPs
whose zygosity was questioned). We encourage other
investigators of autism to see whether our intriguing
finding is replicated in their data sets.
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